However, the precise role of MAPK1 in the progression of ALS remains to be further investigated, including changes in its downstream signaling pathways and its direct impact on MN survival, in order to clarify whether the ERK signaling pathway serves as a primary target through which VPA and ALA exert their neuroprotective effects. The gene discussed is MAPK1; the disease is amyotrophic lateral sclerosis.